Recursion Pharmaceuticals
clinical phase trial initiated in enrollment criteria outcome measures trial update tupelo for underway | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
112 of 143
Related slides by other companies
Arbutus Biopharma
Investor Presentation
November 2023
phase a clinical trial a placebo weeks will be presented at | Arbutus Biopharma
Aeglea BioTherapeutics
Investor Presentation
March 2023
phase clinical trial to generate proof of concept and path to pivotal trial | Aeglea BioTherapeutics
Anebulo Pharmaceuticals
Investor Day
September 2022
clinical trial design part a challenge study | Anebulo Pharmaceuticals
ATAI
Investor Presentation
January 2024
demonstrated a rapid and dose dependent effect along with a safety profile target engagement demonstrated safe well tolerated sedation comparable to placebo phase study trial design results summary | ATAI
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io